Skip to main content
. 2022 Aug 18;13:952852. doi: 10.3389/fimmu.2022.952852

Figure 1.

Figure 1

SeMet inhibits the infectivity of PDCoV. (A) LLC-PK1 were infected with PDCoV (100 TCID50 = 10-2.15) for 1.5 h and treated with 0~150 μM of SeMet. Cells were collected after 48 h for qRT-PCR of viral M gene (n=6). (B) At 48 h treatment with SeMet, PDCoV (100 TCID50) replication in LLC-PK1 cells was determined by indirect immunofluorescence assay (IFA). (C) LLC-PK1 cells were infected with PDCoV for 1.5 h and treated with SeMet (150 μM) for 6, 24, and 48 (h) Expression level of viral mRNAs was analyzed by qRT-PCR (n=6). (D) At 6~48 h treatment with SeMet, PDCoV replication in LLC-PK1 cells was determined by IFA. Means ± SD are shown. Statistical significance was determined by Student t test. ***, P<0.001; **, P<0.01; *, n.s, not significant. All experiments were repeated at least twice and representative results are shown.